Results 151 to 160 of about 1,021,856 (349)

CORONARY HEART DISEASE;

The Professional Medical Journal, 2014
Objective: This study was done to find any correlation among total cholesterol, triglycerides, low density lipoprotein cholesterol and high density lipoprotein cholesterol estimated in serum of offsprings of coronary heart disease patients. Study Design: A cross sectional comparative study.
openaire   +2 more sources

Secondary prevention in coronary heart disease: baseline survey of provision in general practice [PDF]

, 1998
Neil Campbell, J. Thain, H G. Deans, Lewis Ritchie, John Rawles   +4 more
openalex   +1 more source

Microgel‐Based Hierarchical Porous Hydrogel Patch with Adhesion and Resilience for Myocardial Infarction

Advanced Science, EarlyView.
This study develops a hierarchically porous hydrogel patch strategy (HPMP), based on gas‐shearing microfluidics and an aqueous two‐phase system to fabricate porous microgels as microgel‐based bioinks. The porous microgels with controllable porous structure exhibit excellent cellular behavior.
Ziyang Liu, Leyan Xuan, Yingying Hou, Ting Xie, Jieting Li, Junjie Cai, Siyu Zhang, Yingling Miao, Ning Hou, Gen He, Maobin Xie, Xiyong Yu, Mingen Xu, Guosheng Tang   +13 more
wiley   +1 more source

PREVENTING CORONARY HEART-DISEASE [PDF]

The Lancet, 1977
openaire   +2 more sources

Application of Motivational Interview Combined with Staged Nursing in Treatment of Coronary Heart Disease Patients [PDF]

, 2021
Zheng Wei, Y. P. Zhang
openalex   +1 more source

CD147/Basigin: From Integrative Molecular Hub to Translational Therapeutic Target

Advanced Science, EarlyView.
This review conceptualizes CD147 as a fundamental “Energy‐Structure Coupler,” physically bridging metabolic flux (via MCTs) with morphogenetic plasticity (via integrins/MMPs) to drive cancer, infection, and autoimmunity. Addressing the “specificity paradox” that limits current translation, the authors chart a strategic roadmap—spanning logic‐gated ...
Xiang‐Min Yang, Huijie Bian, Zhi‐Nan Chen   +2 more
wiley   +1 more source

The clinical role of combined circulating complement C1q and AIP for CAD with LDL-C level below 1.8mmol/L

Lipids in Health and Disease
Background In the past few years, circulating complement C1q involvement in atherosclerosis has garnered growing research interest in addition to the emerging recognition of the novel lipid marker named atherogenic index of plasma (AIP).
Chenyujun Hu, Zehao Zhao, Shutong Dong, Qianyun Guo, Yujie Zhou   +4 more
doaj   +1 more source

Differences in Medical Treatment of Chronic Coronary Heart Disease Patients According to Medical Specialities [PDF]

, 2009
Alberto Cordero, Vicente Bertoméu, Pilar Mazón, Juan Quiles, Joaquín Aznar, Héctor Bueno   +5 more
openalex   +1 more source

Associations of genetic and infectious risk factors with coronary heart disease [PDF]

, 2022
Flavia Hodel, Zhi Xu, Christian W. Thorball, Roxane de La Harpe, Prunelle Letang-Mathieu, Nicole Brenner, Julia Butt, Noemi Bender, Tim Waterboer, Pedro Marques‐Vidal, Péter Vollenweider, Julien Vaucher, Jacques Fellay   +12 more
openalex   +1 more source

Migrasomes in Ischemic Stroke: Molecular Landscape and Pathophysiological Impact

Advanced Science, EarlyView.
Multi‐omics profiling of stroke patients exposes systemic molecular fingerprints of immune activation, oxidative stress and metabolic collapse. Complement and coagulation cascade, and cholesterol metabolism emerge as shared functional hallmarks of plasma migrasomes in stroke patients and migrasomes isolated from experimental stroke mice.
Huifen Zhou, Yingying Zhang, Peng Zhou, Haofang Wan, Lingling Li, Bin Xu, Yuping Wan, Yingming Song, Yi Kang, Hongbo Zhang, Min Shi, Qun Hou, Jiehong Yang, Chen Ding, Wei Fu, Buchang Zhao, Haitong Wan   +16 more
wiley   +1 more source